Breast Neoplasms: all 12,820 studies
Page 77 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCRStatus unknownNCT03947736
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.Status unknownNCT03947242Not applicable
- Cyberknife for Early Stage Breast CancerCompletedNCT03946683Not applicable
- Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast CancerCompletedNCT03946579Not applicable
- BAriaTric Surgery After Breast Cancer Treatment (BATS)WithdrawnNCT03946423Not applicable
- KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast CancerActive, not recruitingNCT03946202Phase 2
- A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer PatientsActive, not recruitingNCT03945721Phase 1
- A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBCCompletedNCT03945604Phase 1
- Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.CompletedNCT03944499Phase 1
- FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast CancerActive, not recruitingNCT03944434Phase 2
- Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer?CompletedNCT03944226Not applicable
- Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast CancerCompletedNCT03941743Phase 1
- Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After TreatmentTerminatedNCT03941639
- Regional Anesthesia for Breast SurgeryWithdrawnNCT03941223Not applicable
- Proton Accelerated Partial Breast IrradiationWithdrawnNCT03940248Phase 2
- A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast CancerStatus unknownNCT03939871Phase 2
- Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot StudyStatus unknownNCT03939598
- Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast CancerActive, not recruitingNCT03939156
- Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerActive, not recruitingNCT03937154Phase 3
- Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast CancerTerminatedNCT03936933Phase 3
- Guided Imagery & Music in CancerStatus unknownNCT03936075Not applicable
- Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant RadiotherapyCompletedNCT03935802
- A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerStatus unknownNCT03933982Phase 2
- Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast CancerStatus unknownNCT03933319Phase 2
- Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast CancerStatus unknownNCT03932526Phase 2
- Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer PatientsCompletedNCT03931928Phase 2
- Photoacoustic Lymph Node ImagingTerminatedNCT03931655
- Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast CancerTerminatedNCT03931551Phase 2
- Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast FindingsCompletedNCT03929783Not applicable
- Digoxin Induced Dissolution of CTC ClustersCompletedNCT03928210Early Phase 1
- Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)Active, not recruitingNCT03927768
- A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast CancerStatus unknownNCT03927456Phase 3
- Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionActive, not recruitingNCT03927027Phase 3
- Breast Cancer Treatment Based on Organ-like CultureStatus unknownNCT03925233
- Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer PatientsCompletedNCT03924609
- Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing RadiotherapyCompletedNCT03924011Not applicable
- Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing TxCompletedNCT03923504Not applicable
- Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast CancerStatus unknownNCT03923179Phase 2
- Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast CancerStatus unknownNCT03923166Phase 2
- Promoting Early Detection of Breast Cancer in Rural Rwanda: Impact of Community Health Worker and Nurse TrainingCompletedNCT03919682Not applicable
- Hypertension Management in Cancer PatientsTerminatedNCT03919214Not applicable
- Study for the Knowledge of Risk Factors Associated With Breast Cancer in WomenCompletedNCT03918668
- Single Pre-Operative Radiation Therapy - With Delayed Surgery for Low Risk Breast CancerActive, not recruitingNCT03917498Not applicable
- Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerActive, not recruitingNCT03917082Phase 2
- Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation TherapyTerminatedNCT03916068Phase 2
- Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention PilotCompletedNCT03913936Not applicable
- Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer PatientsStatus unknownNCT03913234Phase 1/2
- Chronic Pain and Minor Breast Cancer SurgeryCompletedNCT03912948
- Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast CancersActive, not recruitingNCT03911973Phase 1/2
- Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast TumorsCompletedNCT03911453Early Phase 1
- Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCStatus unknownNCT03910712Phase 2
- Efficacy Study of Mepitel Film the Prophylaxis of Radiation-Induced Skin Reactions in Breast Cancer PatientsCompletedNCT03910595Not applicable
- A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2Status unknownNCT03908749
- Alpha-Lipoic Acid in Breast Cancer PatientsCompletedNCT03908528Not applicable
- Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast CancerStatus unknownNCT03907800Phase 2
- Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast CancerStatus unknownNCT03907098Phase 2
- Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBCTerminatedNCT03905343Phase 3
- Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast CancerActive, not recruitingNCT03904173
- Effect of Quilting Sutures on Post-operative Drainage After Mastectomy and/or Axillary Lymph Node DissectionTerminatedNCT03902977Not applicable
- Needs Assessment After Cancer in Patients Treated for Breast CancerCompletedNCT03902964
- Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast CancerActive, not recruitingNCT03900884Phase 1
- PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS RateActive, not recruitingNCT03900637Phase 2
- Endometrial Changes in Breast Cancer Women With or Without Hormonal TherapiesCompletedNCT03898947
- EMDR Psychotherapy for Anxious-depressive Symptoms in Breast Cancer PatientCompletedNCT03898453Not applicable
- Real World Study of Lapatinib Among Metastatic Breast Cancer PatientsCompletedNCT03894410
- Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast CancerTerminatedNCT03894007Phase 2
- Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast CancerActive, not recruitingNCT03892655
- ModraDoc006/r in Patients With Breast CancerCompletedNCT03890744Phase 2
- Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics TestsCompletedNCT03889171
- Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast CancerCompletedNCT03888677Phase 3
- Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast NodulesStatus unknownNCT03887598
- Breast Cancer Diet Intervention StudyCompletedNCT03886389Not applicable
- Breast Cancer and Its Relationship With the MicrobiotaActive, not recruitingNCT03885648
- TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After SurgeryStatus unknownNCT03881878Phase 1/2
- MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBCActive, not recruitingNCT03881605Not applicable
- Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer PatientsStatus unknownNCT03881384
- The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast CancerCompletedNCT03880799Not applicable
- Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart FailureTerminatedNCT03879629Phase 2
- Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 MutationStatus unknownNCT03879174Phase 2
- Safety and Pharmacokinetics of ODM-209CompletedNCT03878823Phase 1/2
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma BreastActive, not recruitingNCT03878342Not applicable
- A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .Status unknownNCT03878017Not applicable
- Long-term Effects of Breast Cancer TreatmentCompletedNCT03877029
- The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair DeficiencyStatus unknownNCT03876886Phase 3
- Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBCStatus unknownNCT03876587Phase 2
- Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:Active, not recruitingNCT03875573Phase 2
- Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast CancerCompletedNCT03874598Not applicable
- A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast CancerCompletedNCT03872791Phase 1/2
- Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast CancerWithdrawnNCT03872505Phase 2
- Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer PatientsCompletedNCT03872141
- Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer PatientsActive, not recruitingNCT03870919Not applicable
- Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During ChemotherapyCompletedNCT03868865Not applicable
- Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket)CompletedNCT03868514
- Evaluating a Digital Tool for Supporting Breast Cancer PatientsStatus unknownNCT03866655Not applicable
- Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint DiseaseActive, not recruitingNCT03865992Not applicable
- MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast CancerWithdrawnNCT03863301Phase 2
- A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast CancerStatus unknownNCT03863223Phase 3
- Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema ScreeningActive, not recruitingNCT03861975Not applicable
- A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsTerminatedNCT03861403Phase 1